White paper

Non-clinical aspects of RNA-based drug development

Non-clinical aspects of RNA-based drug development

Author: Dr Anika Schröter


Classification of drugs, impact on non-clinical program, class-specific considerations

The development of RNA-based drugs has increased within the past years and is a promising field of research in the pharmaceutical industry. It is transforming the industry and will offer new hope for patients with unmet medical needs.

RNA-based drugs have several advantages over conventional drugs, such as the ability to target previously undruggable pathways, the rapid and cost-effective development, and the potential for personalized medicine. However, RNA-based drugs also face some challenges, such as the stability, delivery, and safety of the RNA molecules.

This whitepaper informs about the challenges with the 'standard' non-clinical program for different RNA-based drugs, focusing on safety evaluation.

Download now the white paper 'Non-clinical aspects of RNA-based drug development'.

We hope you enjoy reading it!


White paper

Non-clinical aspects of RNA-based drug development



Once you have completed the following fields, you can download the desired content. Alternatively, log in to your customer portal. The document will then be freely available to you.
I agree that the FORUM Institut may contact me to inform me about events and relevant content.
I can revoke my permission at any time.
9 + 3 =   

Events “

Do filter
Global Regulatory Affairs Manager

With this qualification course, you can continue your education in a structured manner in all global regulatory affairs topics, with a regional or country-specific focus.

Webcast series "From Lab to Launch: Technical CMC and Non-Clinical Development of RNA/DNA-based drugs"

RNA-/DNA-based drugs: gain a solid understanding of the complexities involved in the development and regulatory approval of RNA-based drugs and oligonucleotides. Meet outstanding and longtermin experienced experts in the field of research.

online 11/09/-11/12/2024
Marketing Authorisation in Latin America

An online seminar to discuss real cases/challenges for marketing authorisation in Mexico, Argentina, Colombia, Peru, Chile and Brazil with local experts from Brazil and Spain.

online 26-27/09/2024
IP Management in Practice

The IP Management in Practice online course was developed in cooperation with a network of experienced IP Managers, IP Directors, and Heads of IP working in various industries and from private practice. Each course day includes a mix of theory and practice. The course content has been chosen with regard to practical application in daily practice.

online 15/10/-15/11/2024
PharmaFORUM Webcast International

Our global and local experts will update you every two months with the latest regulatory and legislative developments. Thus, you will always have the essential information and trends in regulatory affairs at your fingertips!

Certification Audit of EU Agricultural Funds (EAGF, EAFRD) Expenditures in the Programming Period 2023-2027

Familiarize yourself with and explore the basic regulatory requirements and certification audit guidelines for auditing EU agricultural funds expenditures in the 2023-2027 programming period.

online 05-06/11/2024
Employee Inventions and International R&D

This online course shall provide a sound overview about different local laws in important countries in EU and beyond with respect to employee invention rights. It shall enable the participants to address complex situations when designing and negotiating agreements for cross-border R&D.

online 28/11/2024
Supervisory Board Members in German Financial Institutions

Our experienced speakers will help you prepare for all the challenges that supervisory boards face.

online 29/11/2024
Management Board Members in German Financial Institutions

Our experienced speakers will help you prepare for all the challenges facing board members in German banks.

online 29/11/2024
Bank Accounting according to HGB and IFRS

Gain a thorough understanding of the latest accounting standards for national and international banks through detailed examples, all available online.

online 03/12/2024
Unlocking Investment in Biodiversity Finance

In the face of constrained EU and national budgets, innovative funding is needed to support the implementation of biodiversity objectives. Be part of the conversation as we unravel the current challenges and explore solutions for financing biodiversity and our future.

Prague 04/12/2024